Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland

New Microbiologica

Volumn 35, Issue 3, 2012, Pages 317-325

  Nowak, Pawel ^a   Paluchowska, Paulina ^a   Budak, Alicja ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

Author keywords

Acinetobacter baumannii; Cabapenem resistant; OXA

Indexed keywords

ACINETOBACTER BAUMANNII;

BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE OXA 40, ACINETOBACTER BAUMANNII; BETA-LACTAMASE OXA-40, ACINETOBACTER BAUMANNII; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BURN; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOGENICITY; POLAND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; BURN UNITS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTAGENESIS, INSERTIONAL; POLAND;

EID: 84864567606     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. BERTINI A., GIORDANO A., VARESI P., VILLA L., MANCINI C., CARATTOLI A. (2006). First report of the car-bapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob Agents Chemother. 50, 2268-2269. (Pubitemid 43807563)
2. BOGAERTS P., NAAS T., WYBO I., BAURAING C., SOETENS O., PIÉRARD D., NORDMANN P., GLUPCZYNSKI Y. (2006). Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapen-emase OXA-58 in Belgium. J. Clin. Microbiol. 44, 4189-4192. (Pubitemid 44737268)
3. BRATU S., LANDMAN D., MARTIN D. A., GEORGESCU C., QUALE J. (2008). Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob Agents Chemother. 52, 2999-3005.
4. VAN DEN BROEK P. J., ARENDS J., BERNARDS A. T., DE BRAUWER E., MASCINI E. M., VAN DERREIJDEN T. J. K., SPANJAARD L., THEWESSEN E. A. P. M., VAN DER ZEE A., VAN ZEIJL J. H., DIJKSHOORN L. (2006). Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin. Microbiol. Infect. 12, 837-843. (Pubitemid 44151283)
5. CARVALHO K. R., CARVALHO-ASSEF A. P., PEIRANO G., SANTOS L. C., PEREIRA M. J., ASENSI M. D. (2009). Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int. J. Antimicrob. Agents. 34, 25-28.
6. CASTANHEIRA M., WANGER A., KRUZEL M., DESHPANDE L. M., JONES R. N. (2008). Emergence and clonal dissemination of OXA-24 and OXA-58 producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program. J. Clin. Microbiol. 46, 3179-3180.
7. CLSI. (2008). Performance standards for antimicrobial susceptibility testing, 18th informational supplement. CLSI/NCCLS document M100-S18. Clinical and Laboratory Standards Institute.
8. COELHO J., WOODFORD N., AFZAL-SHAH M., LIVERMORE D. (2006). Occurrence of OXA-58-like carbapene-mases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50, 756-758. (Pubitemid 43190994)
9. EVANS B. A., HAMOUDA A., TOWNER K. J., AMYES S. G. (2008). OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin. Microbiol. Infect. 14, 268-275. (Pubitemid 351201018)
10. FLEISCHER M., FRANICZEK R., BORTKIEWICZ O., STANKIEWICZ M., GRABOWSKI M., FLEISCHER K. (2002). Comparative in vitro activity of carbapen-ems against Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the intensive care unit. Clin. Microbiol. Infect. 8(Suppl. 1), 364.
11. FOURNIER P. E., RICHET H. (2006). The epidemiology and control of Acinetobacter baumanniiin health care facilities. Clin. Infect. Dis. 42, 692-699. (Pubitemid 43271386)
12. GARNACHO-MONTERO J., AMAYA-VILLAR R. (2010). Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr. Opin. Infect. Dis. 23, 332-339.
13. GORDON N. C., WAREHAM D. W. (2010). Multidrug-resist-ant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents. 35, 219-26.
14. GROSSO F., QUINTEIRA S., PEIXE L. (2011). Understanding the dynamics of imipenem-resist-ant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. Jan 24. doi: 10.1111/j.1469 0691.2011.03469.x.
15. GÜDÜCÜOGLU H., DURMAZ R., YAMAN G., CIZMECI Z., BERKTAS M., DURMAZ B. (2005). Spread of a single clone Acinetobacter baumannii strain in an intensive care unit of a teaching hospital in Turkey. New Microbiol. 28, 337-343. (Pubitemid 41820617)
16. HÉRITIER C., DUBOUIX A., POIREL L., MARTY N., NORDMANN P. (2005) a. A nosocomial outbreak of Acinetobacter baumanniiisolates expressing the car-bapenem-hydrolysing oxacillinase OXA-58. J. Antimicrob. Chemother. 55, 115-118. (Pubitemid 40192624)
17. HÉRITIER C., POIREL L., FOURNIER P. E., CLAVERIE J. M., RAOULT D., NORDMANN P. (2005) b. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49, 4174-4179. (Pubitemid 41400961)
18. LOLANS K., RICE T. W., MUNOZ-PRICE L. S., QUINN J. P. (2006). Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the car-bapenemase OXA-40. Antimicrob. Agents Chemother. 50, 2941-2945. (Pubitemid 44396395)
19. MARAGAKIS L. L., PERL T. M. (2008). Acinetobacter bau-mannii: epidemiology, antimicrobial resistance and treatment options. Clin. Infect. Dis. 46, 1254-1263. (Pubitemid 351589912)
20. MARQUÉ S., POIREL L., HÉRITIER C., BRISSE S., BLASCO M. D., FILIP R., COMAN G., NAAS T., NORDMANN P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol. 43, 4885-4888. (Pubitemid 41298303)
21. MENDES R. E., BELL J. M., TURNIDGE J. D., CASTANHEIRA M., JONES R. N. (2009) a. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacterspp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63, 55-59.
22. MENDES R. E., BELL J. M., TURNIDGE J. D., CASTANHEIRA M., DESHPANDE L. M., JONES R. N. (2009) b. Codetection of blaOXA-23-like gene (bla-OXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 53, 843-844.
23. MUGNIER P. D., POIREL L., NAAS T., NORDMANN P. (2010). Worldwide dissemination of the blaOXA-23 car-bapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16, 35-40.
24. PELEG A. Y., SEIFERT H., PATERSON D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582.
25. PEREZ F., HUJER A. M., HUJER K. M., DECKER B. K., RATHER P. N., BONOMO R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471-3484. (Pubitemid 47519332)
26. PLAYFORDE. G., CRAIG J. C., IREDELL J. R. (2007). Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect. 65, 204-211.
27. POIREL L., NORDMAN P. (2006) a. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836. (Pubitemid 44151282)
28. POIREL L., NAAS T., NORDMANN P. (2010). Diversity, epidemiology and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54, 24-38.
29. POIREL L., FIGUEIREDO S., CATTOIR V., CARATTOLI A., NORDMANN P. (2008). Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents. Chemother. 52, 1252-1256. (Pubitemid 351521984)
30. POIREL L., MARQUÉ S., HÉRITIER C., SEGONDS C., CHABANON G., NORDMANN P. (2005). OXA-58, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49, 202-208. (Pubitemid 40065794)
31. POIREL L., LEBESSI E., HÉRITIER C., PATSOURA A., FOUSTOUKOU M., NORDMANN P. (2006) b. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a pediatric hospital in Greece. Clin. Microbiol. Infect. 12, 1138-1141. (Pubitemid 44462851)
32. ROSSOLINI G. M., MANTENGOLI E., DOCQUIER J. D., MUSMANNO R. A., CORATZA G. (2007). Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiol. 30, 332-339. (Pubitemid 47264901)
33. QI C., MALCZYNSKI M., PARKER M., SCHEETZ M. H. (2008). Characterization of genetic diversity of carbapen-em-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46, 1106-1109. (Pubitemid 351380009)
34. QUINTEIRA S., GROSSO F., RAMOS H., PEIXE L. (2007). Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter bau-mannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital. Antimicrob. Agents Chemother. 51, 3465-3466. (Pubitemid 350067584)
35. ROBERTS S. A., FINDLAY R., LANG S. D. (2001). Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J. Hosp. Infect. 48, 228-32. (Pubitemid 32677709)
36. RUIZ M., MARTI S., FERNANDEZ-CUENCA F., PASCUAL A., VILA J. (2007). High prevalence of carbapenem-hy-drolysingoxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect. 13, 1192-1198.
37. SCAIFE W., YOUNG H. K., PATON R. H., AMYES S. G. (1995). Transferable imipenem-resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 36, 585-586.
38. SEGAL H., GARNY S., ELISHA B. G. (2005). Is IS (ABA-1) customized for Acinetobacter? FEMS Microbiol Lett. 243, 425-429.
39. SIMOR A. E., LEE M., VEARNCOMBE M., JONES-PAUL L., BARRY C., GOMEZ M., FISH J. S., CARTOTTO R. C., PALMER R., LOUIE M. (2002). An outbreak due to multi-resistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect. Control. Hosp. Epidemiol. 23, 261-267. (Pubitemid 34525269)
40. STOEVA T., HIGGINS P. G., SAVOV E., MARKOVSKA R., MITOV I., SEIFERT H. (2009). Nosocomial spread of OXA-23 and OXA-58 β-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital. Antimicrob. Chemother. 63, 618-620.
41. STOEVA T., HIGGINS P. G., BOJKOVA K., SEIFERT H. (2008). Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. Clin. Microbiol. Infect. 14, 723-727. (Pubitemid 351837035)
42. TAHERIKALANI M., FATOLAHZADEH B., EMANEINI M., SOROUSH S., FEIZABADI M. M. (2009). Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 32, 265-271.
43. TOWNER K. J., EVANS B., VILLA L., LEVI K., HAMOUDA A., AMYES S. G., CARATTOLI A. (2011). Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D beta-lac-tamase genes in european clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 55, 2154-2159.
44. OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976. (Pubitemid 44228598)
45. TURTON J. F., KAUFMANN M. E., GLOVER J., COELHO J. M., WARNER M., PIKE R., PITT T. L. (2005). Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43, 3074-3082. (Pubitemid 40981305)
46. TURTON J. F., WARD M. E., WOODFORD N., KAUFMANN M. E., PIKE R., LIVERMORE D. M., PITT T. L. (2006) b. The role of ISAba1 in expression of OXA car-bapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72-77.
47. WALSH T. R. (2010). Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents. 36(suppl 3), S8-S14.
48. WOODFORD N., ELLINGTON M. J., COELHO J. M., TURTON J. F., WARD M. E., BROWN S., AMYES S. G., LIVERMORE D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27, 351-353.
49. WROBLEWSKA M. M., RUDNICKA J., MARCHEL H., LUCZAK M. (2006). Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units. Int. J. Antimicrob. Agents. 27, 285-289.
50. WROBLEWSKA M. M., TOWNER K. J., MARCHEL H., LUCZAK M. (2007). Emergence and spread of carbapenem resistant strains of in a tertiary-care hospital in Poland. Clin. Microbiol. Infect. 13, 490-496. (Pubitemid 46563498)
51. ZAVACSKI A. P., CARVALHAES C. G., PICAO R. C., GALES A. C. (2010). Multidrug-resistant Pseudomonas aerugi-nosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev. Anti Infect. Ther. 8, 71-93.